Martin Ventures invests in oncology tech firm

Local investment firm Martin Ventures has taken part in a $7.25 million funding round for an Atlanta company that markets software for oncology treatments.

OncoLens’ products aggregate and organize data from cases and clinical trials and lets providers and patients sketch out treatment plans and collaborate in various ways. The company’s funding round was led by existing investor BIP Capital; the Martin Ventures team was also joined by fellow new investor SeedToB Capital.